🏆 Deal of the Week · KW 4/2026
Neko Health raised USD 260 million in a Series B round at a valuation of USD 1.8 billion, announced in January 2025. The round was led by Lightspeed Venture Partners. The funding will support the company's expansion of its preventive health scanning technology.
Neko Health — key deal facts
| Company | Neko Health |
| Founded | 2018 |
| Headquarters | Stockholm, Sweden |
| Amount raised | USD 260m |
| Valuation | USD 1.8b |
| Round | Series B |
| Investors | The round was led by Lightspeed Venture Partners, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar and Atomico |
| Sectors | HealthTech |
Who invested in Neko Health?
Lightspeed Venture Partners led the Series B, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico. The syndicate combines US-based generalist growth funds with European technology investors, reflecting cross-Atlantic conviction in Neko Health's preventive care model. The presence of Atomico and Lakestar, both with strong Nordic and European HealthTech track records, is particularly notable given the company's Stockholm base.
What does Neko Health do?
Neko Health is a Stockholm-based HealthTech company founded in 2018 by Daniel Ek, co-founder of Spotify, and Hjalmar Nilsonne, who serves as CEO. The company's core product is the Neko Body Scan, a 60-minute non-invasive health assessment that captures millions of data points across skin, heart, blood, and circulation. The scan is delivered through proprietary hardware — Derma, Spectrum, and Echo — all designed, engineered, and assembled in Sweden. Neko Health's mission is to shift healthcare from reactive treatment to preventive early detection.
Neko Health valuation & multiples
Explore the benchmarks: Series B HealthTech.
Frequently asked questions
How much did Neko Health raise in its Series B?
Neko Health raised USD 260 million in its Series B round, announced in January 2025.
What is Neko Health's valuation?
Neko Health was valued at USD 1.8 billion at the time of its Series B round.
Who invested in Neko Health?
The Series B was led by Lightspeed Venture Partners, with participation from General Catalyst, O.G. Venture Partners, Rosello, Lakestar, and Atomico.
When was Neko Health founded and where is it based?
Neko Health was founded in 2018 and is headquartered in Stockholm, Sweden.
Source: original announcement — read the full report.